Dr. Reimuth Discusses Studies Looking at Resistance to EGFR TKIs in NSCLC
April 25th 2019Niels Reinmuth, MD, PhD, leader of the Thoracic Oncology Department, Asklepios Lung Clinic, discusses ongoing studies looking at resistance to EGFR TKIs in patients with EGFR-positive non–small cell lung cancer.
Read More